No products
View larger AT15713
1000 Items
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $89.25 | Total: $446.25 |
| 1 | 10 | $75.60 | Total: $756.00 |
| 1 | 25 | $64.05 | Total: $1,601.25 |
| 1 | 50 | $54.60 | Total: $2,730.00 |
| 1 | 100 | $47.25 | Total: $4,725.00 |
| Molecular Formula | C45H53NO14 |
| Molecular Weight | 831.9 |
| CAS Numbers | 156294-36-9 |
| Storage Condition | 0C Short Term, -20C Long Term |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | [H][C@@]12C[C@@H]3C[C@@]33C(=O)[C@]([H])(OC(C)=O)C4=C(C)[C@@H](C[C@@](O)([C@@H](OC(=O)c5ccccc5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c1ccccc1 |
| References | Zatloukal P, et al. Randomized multicenter phase II study of larotaxel [XRP9881] in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer. J Thorac Oncol. 2008 Aug;3[8] 894-901. |